Clinical implications of germline mutations in breast cancer: TP53

被引：0
|
作者：
Katherine Schon
Marc Tischkowitz
机构：
[1] Cambridge University Hospitals NHS Trust,East Anglian Medical Genetics Service
[2] University of Cambridge,Department of Medical Genetics and National Institute for Health Research Cambridge Biomedical Research Centre
[3] Cambridge Biomedical Campus,Department of Medical Genetics, Addenbrooke’s Treatment Centre
来源：
Breast Cancer Research and Treatment | 2018年 / 167卷
关键词：
Gene panel testing; Li–Fraumeni syndrome;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：417 / 423
页数：6
相关论文
共 50 条
  • [1] Clinical implications of germline mutations in breast cancer: TP53
    Schon, Katherine
    Tischkowitz, Marc
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 167 (02) : 417 - 423
  • [2] Germline mutations of TP53 gene in breast cancer
    Damineni, Surekha
    Rao, Vadlamudi Raghavendra
    Kumar, Satish
    Ravuri, Rajasekar Reddy
    Kagitha, Sailaja
    Dunna, Nageswara Rao
    Digumarthi, Raghunadharao
    Satti, Vishnupriya
    TUMOR BIOLOGY, 2014, 35 (09) : 9219 - 9227
  • [3] Prevalence and clinical impact of TP53 germline mutations in Chinese women with breast cancer
    Sheng, Shuyan
    Xu, Ye
    Guo, Yonghai
    Yao, Lu
    Hu, Li
    Ouyang, Tao
    Li, Jinfeng
    Wang, Tianfeng
    Fan, Zhaoqing
    Fan, Tie
    Lin, Benyao
    Xie, Yuntao
    INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (02) : 487 - 495
  • [4] TP53 germline mutations in the context of families with hereditary breast and ovarian cancer: a clinical challenge
    Grill, Sabine
    Ramser, Juliane
    Hellebrand, Heide
    Pfarr, Nicole
    Boxberg, Melanie
    Brambs, Christine
    Ditsch, Nina
    Meindl, Alfons
    Gross, Eva
    Meitinger, Thomas
    Kiechle, Marion
    Quante, Anne S.
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2021, 303 (06) : 1557 - 1567
  • [5] TP53 germline mutations in the context of families with hereditary breast and ovarian cancer: a clinical challenge
    Sabine Grill
    Juliane Ramser
    Heide Hellebrand
    Nicole Pfarr
    Melanie Boxberg
    Christine Brambs
    Nina Ditsch
    Alfons Meindl
    Eva Groß
    Thomas Meitinger
    Marion Kiechle
    Anne S. Quante
    Archives of Gynecology and Obstetrics, 2021, 303 : 1557 - 1567
  • [6] Clinical Features of Breast Cancer in South Korean Patients with Germline TP53 Gene Mutations
    Alyami, Hassan
    Yoo, Tae Kyung
    Cheun, Jong Ho
    Lee, Han Byoel
    Jung, Sung Mi
    Ryu, Jai Min
    Bae, Soong June
    Jeong, Joon
    Yoon, Chang Ik
    Ahn, Juneyoung
    Paik, Pill Sun
    Cho, Min Kyung
    Park, Woo Chan
    JOURNAL OF BREAST CANCER, 2021, 24 (02) : 175 - 182
  • [7] Impact of germline TP53 mutations and polymorphisms in women with premenopausal breast cancer
    Samuel, Nardin
    Novokmet, Ana
    Hudson, Thomas J.
    Malkin, David
    CANCER RESEARCH, 2014, 74 (23)
  • [8] Germline mutations in the TP53 gene
    Eeles, RA
    CANCER SURVEYS, 1995, 25 : 101 - 124
  • [9] Impact of TP53 mutations in breast cancer: Clinicopathological features and prognosisImpact of TP53 mutations in breast CA
    Li, Xuerui
    Chen, Xiaoqing
    Wen, Lingzhu
    Wang, Yulei
    Chen, Bo
    Xue, Yunlian
    Guo, Liping
    Liao, Ning
    THORACIC CANCER, 2020, 11 (07) : 1861 - 1868
  • [10] TP53 Mutations in Breast and Ovarian Cancer
    Silwal-Pandit, Laxmi
    Langerod, Anita
    Borresen-Dale, Anne-Lise
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2017, 7 (01):
12345